A Phase II Study of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) as Front Line Therapy for Patients With Peripheral T-Cell Lymphoma (PTCL): Final Results From the T- Cell Consortium Trial
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.13855
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 2, 2015
Authors
Publisher
Wiley